Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy
The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and sur...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Li, Xuemeng [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022transfer abstract |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China - Deng, Lixing ELSEVIER, 2022, the official journal of the Italian Pharmacological Society, London |
|---|---|
| Übergeordnetes Werk: |
volume:179 ; year:2022 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.phrs.2022.106218 |
|---|
| Katalog-ID: |
ELV057726876 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV057726876 | ||
| 003 | DE-627 | ||
| 005 | 20230626045632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220808s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phrs.2022.106218 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica |
| 035 | |a (DE-627)ELV057726876 | ||
| 035 | |a (ELSEVIER)S1043-6618(22)00163-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 330 |q VZ |
| 100 | 1 | |a Li, Xuemeng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| 264 | 1 | |c 2022transfer abstract | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. | ||
| 520 | |a The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. | ||
| 650 | 7 | |a Photothermal therapy |2 Elsevier | |
| 650 | 7 | |a Photodynamic therapy |2 Elsevier | |
| 650 | 7 | |a Glioma |2 Elsevier | |
| 650 | 7 | |a Tumor microenvironments |2 Elsevier | |
| 650 | 7 | |a Nanoparticle |2 Elsevier | |
| 650 | 7 | |a Sonodynamic therapy |2 Elsevier | |
| 700 | 1 | |a Geng, Xiaorui |4 oth | |
| 700 | 1 | |a Chen, Zhiyi |4 oth | |
| 700 | 1 | |a Yuan, Zhen |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Deng, Lixing ELSEVIER |t Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |d 2022 |d the official journal of the Italian Pharmacological Society |g London |w (DE-627)ELV008224951 |
| 773 | 1 | 8 | |g volume:179 |g year:2022 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2022.106218 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 179 |j 2022 |h 0 | ||
| author_variant |
x l xl |
|---|---|
| matchkey_str |
lixuemenggengxiaoruichenzhiyiyuanzhen:2022----:eetdacsnloairevrnetepneaoltomfrht |
| hierarchy_sort_str |
2022transfer abstract |
| publishDate |
2022 |
| allfields |
10.1016/j.phrs.2022.106218 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 DE-627 ger DE-627 rakwb eng 330 VZ Li, Xuemeng verfasserin aut Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy 2022transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier Geng, Xiaorui oth Chen, Zhiyi oth Yuan, Zhen oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:179 year:2022 pages:0 https://doi.org/10.1016/j.phrs.2022.106218 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 179 2022 0 |
| spelling |
10.1016/j.phrs.2022.106218 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 DE-627 ger DE-627 rakwb eng 330 VZ Li, Xuemeng verfasserin aut Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy 2022transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier Geng, Xiaorui oth Chen, Zhiyi oth Yuan, Zhen oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:179 year:2022 pages:0 https://doi.org/10.1016/j.phrs.2022.106218 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 179 2022 0 |
| allfields_unstemmed |
10.1016/j.phrs.2022.106218 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 DE-627 ger DE-627 rakwb eng 330 VZ Li, Xuemeng verfasserin aut Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy 2022transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier Geng, Xiaorui oth Chen, Zhiyi oth Yuan, Zhen oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:179 year:2022 pages:0 https://doi.org/10.1016/j.phrs.2022.106218 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 179 2022 0 |
| allfieldsGer |
10.1016/j.phrs.2022.106218 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 DE-627 ger DE-627 rakwb eng 330 VZ Li, Xuemeng verfasserin aut Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy 2022transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier Geng, Xiaorui oth Chen, Zhiyi oth Yuan, Zhen oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:179 year:2022 pages:0 https://doi.org/10.1016/j.phrs.2022.106218 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 179 2022 0 |
| allfieldsSound |
10.1016/j.phrs.2022.106218 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica (DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 DE-627 ger DE-627 rakwb eng 330 VZ Li, Xuemeng verfasserin aut Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy 2022transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier Geng, Xiaorui oth Chen, Zhiyi oth Yuan, Zhen oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:179 year:2022 pages:0 https://doi.org/10.1016/j.phrs.2022.106218 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 179 2022 0 |
| language |
English |
| source |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:179 year:2022 pages:0 |
| sourceStr |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:179 year:2022 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Photothermal therapy Photodynamic therapy Glioma Tumor microenvironments Nanoparticle Sonodynamic therapy |
| dewey-raw |
330 |
| isfreeaccess_bool |
false |
| container_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| authorswithroles_txt_mv |
Li, Xuemeng @@aut@@ Geng, Xiaorui @@oth@@ Chen, Zhiyi @@oth@@ Yuan, Zhen @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008224951 |
| dewey-sort |
3330 |
| id |
ELV057726876 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057726876</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626045632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2022.106218</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057726876</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(22)00163-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Xuemeng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Photothermal therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glioma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor microenvironments</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sonodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geng, Xiaorui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Zhiyi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Zhen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:179</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2022.106218</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">179</subfield><subfield code="j">2022</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Li, Xuemeng |
| spellingShingle |
Li, Xuemeng ddc 330 Elsevier Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| authorStr |
Li, Xuemeng |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008224951 |
| format |
electronic Article |
| dewey-ones |
330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
330 VZ Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy Elsevier |
| topic |
ddc 330 Elsevier Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy |
| topic_unstemmed |
ddc 330 Elsevier Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy |
| topic_browse |
ddc 330 Elsevier Photothermal therapy Elsevier Photodynamic therapy Elsevier Glioma Elsevier Tumor microenvironments Elsevier Nanoparticle Elsevier Sonodynamic therapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
x g xg z c zc z y zy |
| hierarchy_parent_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| hierarchy_parent_id |
ELV008224951 |
| dewey-tens |
330 - Economics |
| hierarchy_top_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008224951 |
| title |
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| ctrlnum |
(DE-627)ELV057726876 (ELSEVIER)S1043-6618(22)00163-3 |
| title_full |
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| author_sort |
Li, Xuemeng |
| journal |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| journalStr |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Li, Xuemeng |
| container_volume |
179 |
| class |
330 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Li, Xuemeng |
| doi_str_mv |
10.1016/j.phrs.2022.106218 |
| dewey-full |
330 |
| title_sort |
recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| title_auth |
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| abstract |
The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. |
| abstractGer |
The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. |
| abstract_unstemmed |
The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy |
| url |
https://doi.org/10.1016/j.phrs.2022.106218 |
| remote_bool |
true |
| author2 |
Geng, Xiaorui Chen, Zhiyi Yuan, Zhen |
| author2Str |
Geng, Xiaorui Chen, Zhiyi Yuan, Zhen |
| ppnlink |
ELV008224951 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.phrs.2022.106218 |
| up_date |
2024-07-06T16:59:06.698Z |
| _version_ |
1803849717987147776 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057726876</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626045632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2022.106218</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001774.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057726876</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(22)00163-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Xuemeng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The newly emerging nanotheranostic strategies including photodynamic therapy (PDT), photothermal therapy (PTT) and sonodynamic therapy (SDT) have exhibited their unbeatable advantages in treatment and prognosis of glioma tumors as compared to conventional ones like chemotherapy, radiotherapy and surgery. Meanwhile, the components of glioma microenvironment including blood brain barrier (BBB), oxidative stress, hypoxia and angiogenesis, play essential roles in glioma initiation, progression, invasion, recurrence and drug resistance. More importantly, the nanoparticles can modulate the glioma environments to increase targeting capability, monitor the glioma growth, and enhance therapy outcomes. In this review, we will introduce the basic components of glioma microenvironment, the role that glioma microenvironment played on tumor development and progression, and the key perspectives associated with glioma microenvironment-based multifunctional nanoplatform design. In particular, recent advances in glioma microenvironment-response nanoparticles for phototherapy (PTT and PDT) and sonotherapy will be discussed in detail. Finally, the challenges related to the clinical transition for nanomedicine-based glioma theranostics will be addressed.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Photothermal therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Photodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glioma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor microenvironments</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sonodynamic therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geng, Xiaorui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Zhiyi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Zhen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:179</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2022.106218</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">179</subfield><subfield code="j">2022</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4004097 |